Function's acquisition of SuppCo integrates supplement verification with biomarker testing, addressing a critical gap in wellness accountability. Roughly half of top-selling supplements fail label accuracy standards, yet consumers lack feedback mechanisms to track whether their supplementation is producing measurable effects.
Key Points
- 50% of top-selling supplements fail basic label accuracy standards
- Integration of supplement data with biomarker testing enables outcome measurement
- SuppCo operates as independent reviewer, not product vendor, removing profit incentive bias
Longevity Analysis
The supplement industry operates largely without accountability mechanisms—consumers spend billions annually without reliable feedback on whether interventions produce measurable physiological change. By linking supplement intake to biomarker data, this acquisition addresses a fundamental problem in evidence-informed health optimization: the inability to decode whether a given intervention is actually working. The finding that half of supplements fail label accuracy exposes a critical interference point that has gone unaddressed. Without verification infrastructure, even well-intentioned supplementation becomes guesswork rather than measured intervention.
Original published by Longevity.Technology, by Kyle Umipig.